Journal article icon

Journal article

MAPK-driven epithelial cell plasticity drives colorectal cancer therapeutic resistance

Abstract:
The colorectal epithelium is rapidly renewing, with remarkable capacity to regenerate following injury. In colorectal cancer (CRC), this regenerative capacity can be co-opted to drive epithelial plasticity. Although oncogenic MAPK signalling in CRC is common, with frequent mutations of both KRAS (40–50%) and BRAF (10%)1, inhibition of this pathway typically drives resistance clinically. Here, given the development of KRAS inhibitors and licensing of BRAF inhibitor combinations2, 3–4, we have interrogated key mechanisms of resistance to these agents in advanced preclinical CRC models. We show that oncogenic MAPK signalling induces epithelial-state changes in vivo, driving adoption of a regenerative/revival stem-like population, whereas inhibition leads to rapid transcriptional remodelling of both Kras-mutant and Braf-mutant tumours, favouring a WNT-associated, canonical stem phenotype. This drives acute therapeutic resistance in Kras-driven and delayed resistance in Braf-driven models. Where plasticity is restrained, such as in early metastatic disease, or through targeting ligand-dependent WNT pathway Rnf43 mutations, marked therapeutic responses are observed. This explains the super response to BRAF + EGFR-targeted therapies previously observed in a BRAF–RNF43 co-mutant patient population, highlighting the criticality of cellular plasticity in therapeutic response. Together, our data provide clear insight into the mechanisms underpinning resistance to MAPK-targeted therapies in CRC. Moreover, strategies that aim to corral stem cell fate, restrict epithelial plasticity or intervene when tumours lack heterogeneity may improve therapeutic efficacy of these agents.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Publisher copy:
10.1038/s41586-025-09916-w

Authors

More by this author
Role:
Author
ORCID:
0000-0002-6309-3254
More by this author
Role:
Author
ORCID:
0009-0000-0922-7912
More by this author
Role:
Author
ORCID:
0009-0000-7596-4275
More by this author
Role:
Author
ORCID:
0000-0003-4607-194X
More by this author
Role:
Author
ORCID:
0000-0001-6683-433X


Publisher:
Nature Research
Journal:
Nature More from this journal
Volume:
650
Issue:
8102
Pages:
748-758
Publication date:
2025-11-24
Acceptance date:
2025-11-14
DOI:
EISSN:
1476-4687
ISSN:
0028-0836


Language:
English
Source identifiers:
3773349
Deposit date:
2026-02-18
ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP